Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-26T06:46:54.290Z Has data issue: false hasContentIssue false

Clofoctol-Induced Ultrastructural Changes In Staphylococcus Aureus

Published online by Cambridge University Press:  02 July 2020

Beverly E. Maleeff
Affiliation:
Departments of Safety Assessment, SmithKline Beecham Pharmaceuticals King of Prussia, PA
Stewart C. Pearson
Affiliation:
Anti-Infectives Research, Collegeville, PA
David J. Payne
Affiliation:
Anti-Infectives Research, Collegeville, PA
Timothy K. Hart
Affiliation:
Departments of Safety Assessment, SmithKline Beecham Pharmaceuticals King of Prussia, PA
Get access

Extract

Clofoctol [2-(2,4-dichlorobenzyl)-4-(tetramethyl-l,l,3,3-butyl) phenol] is a synthetic antibacterial compound with activity against both Gram-positive1 and Gram-negative2 microorganisms. Although the specific mechanism of Clofoctol action has not been fully elucidated, it is reported to alter the permeability of the cytoplasmic membrane in Bacillus subtilis, and is used clinically to treat upper respiratory tract infections in humans. Staphylococcus aureus is a major human Grampositive pathogen that causes a variety of human diseases ranging from localized skin suppuration and food poisoning to life threatening presentations such as septicemia and endocarditis. Several clinical isolates of S. aureus have recently been identified that are resistant to all currently available antibacterial therapies. Consequently, the identification of new antimicrobial targets in this organism is of paramount importance. The purpose of this study was to investigate the in vitro effects of Clofoctol on S. aureus.

Ultrastructural examination of S. aureus revealed a population of actively dividing cells.

Type
Microbiology
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Yablonsky, F, 1983. J. Gen. Microbiology 129:10891095.Google Scholar
2.Buogo, A, 1984. Drugs Exptl. Clin. Res. X(5): 321324.Google Scholar
3.Waldvogel, A, 1985. aureus, S., in Principles and Practice of Infectious Diseases. Mandell et al. Eds., John Wiley & Sons, New York, pp.10971116.Google Scholar
4.Yablonsky, F and Simmonet, G, 1982. J. Pharmacologie 13(4): 515524.Google Scholar